Literature DB >> 7688786

B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells.

S Nonoyama1, D Hollenbaugh, A Aruffo, J A Ledbetter, H D Ochs.   

Abstract

Costimulatory signals provided by T cells are required for B cells to produce specific antibody (Ab) to T-dependent antigen (Ag) bacteriophage phi x 174. In this study, we demonstrate that if cultured in the presence of anti-CD40, interleukin 10 (IL-10), and Ag, purified B cells can produce antiphage Ab in quantities comparable to those synthesized by B cells cocultured with Ag and T cells. Isotypes produced by B cells in this culture system correspond to those observed in sera of B cell donors. Culture of immunoglobulin (Ig)D- and IgD+ B cells reveals that Ag-induced production of antiphage Ab is restricted to IgD- subset of B cells. In the absence of Ag, anti-CD40/IL-10-stimulated B cells produce only minute amounts of antiphage Ab, indicating that Ag stimulation is indispensable and provides a signal that is synergistic with anti-CD40 and IL-10. Addition of a soluble form of the CD40 ligand (sgp39) to the culture system has a similar effect on specific Ab synthesis as anti-CD40; addition of the soluble construct, CD40 Ig, known to inhibit gp39/CD40 interaction, suppresses in vitro antiphage Ab production by Ag exposed peripheral blood mononuclear cells. Finally, in vivo requirement of gp39/CD40 interaction for specific Ab production was demonstrated by the finding that activated T cells from patients with x-linked hyper IgM syndrome express functionally defective gp39 and respond with depressed Ab titers and fail to switch from IgM to IgG after multiple phage immunizations. These observations illustrate that in vitro and possibly in vivo Ag-specific Ab synthesis requires the presence of Ag and IL-10, and activation signals via CD40.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688786      PMCID: PMC2191162          DOI: 10.1084/jem.178.3.1097

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Destruction of some agglutinins but not of others by two sulfhydryl compounds.

Authors:  R GRUBB; B SWAHN
Journal:  Acta Pathol Microbiol Scand       Date:  1958

Review 2.  Cognate interactions between helper T cells and B cells.

Authors:  R J Noelle; E C Snow
Journal:  Immunol Today       Date:  1990-10

3.  Antibody to bacteriophage phi X 174 synthesized by cultured human peripheral blood lymphocytes.

Authors:  J Bohnsack; H D Ochs; R J Wedgwood; S R Heller
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

4.  Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.

Authors:  E A Clark; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody.

Authors:  A Svetić; F D Finkelman; Y C Jian; C W Dieffenbach; D E Scott; K F McCarthy; A D Steinberg; W C Gause
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

6.  Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency.

Authors:  H D Ochs; R H Buckley; R H Kobayashi; A L Kobayashi; R U Sorensen; S D Douglas; B L Hamilton; M S Hershfield
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

7.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

8.  Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets.

Authors:  D F Jelinek; J B Splawski; P E Lipsky
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

9.  Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.

Authors:  M K Spriggs; R J Armitage; L Strockbine; K N Clifford; B M Macduff; T A Sato; C R Maliszewski; W C Fanslow
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.

Authors:  D Hollenbaugh; L S Grosmaire; C D Kullas; N J Chalupny; S Braesch-Andersen; R J Noelle; I Stamenkovic; J A Ledbetter; A Aruffo
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  36 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.

Authors:  K W Wucherpfennig; I Catz; S Hausmann; J L Strominger; L Steinman; K G Warren
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 3.  Divide and conquer: the importance of cell division in regulating B-cell responses.

Authors:  Stuart G Tangye; Philip D Hodgkin
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

4.  Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.

Authors:  M Koshy; D Berger; M K Crow
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  Production of immunoglobulins by human sIgD+ and sIgD- human blood B lymphocytes in response to stimulation with activated T cells and agonistic antibodies; effect of IL-10, IL-2 and mode of activation of T cells.

Authors:  N R Ling; B Brown; D Hardie
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 6.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

Review 7.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Class switch recombination in selective IgA-deficient subjects.

Authors:  L Hummelshoj; L P Ryder; L K Nielsen; C H Nielsen; L K Poulsen
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

9.  Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection.

Authors:  E J Kim; J Kwun; A C Gibby; J J Hong; A B Farris; N N Iwakoshi; F Villinger; A D Kirk; S J Knechtle
Journal:  Am J Transplant       Date:  2014-01       Impact factor: 8.086

10.  Genome-wide analysis of immune activation in human T and B cells reveals distinct classes of alternatively spliced genes.

Authors:  Yevgeniy A Grigoryev; Sunil M Kurian; Aleksey A Nakorchevskiy; John P Burke; Daniel Campbell; Steve R Head; Jun Deng; Aaron B Kantor; John R Yates; Daniel R Salomon
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.